Abstract
Spontaneous bacterial peritonitis (SBP), a common complication of cirrhosis of liver, might result from translocation of bacteria from the small bowel. However, there is scanty data on frequency of small intestinal bacterial overgrowth (SIBO) in patients with cirrhosis of the liver. There are no data on SIBO in patients with extra-hepatic portal venous obstruction (EHPVO) in the literature. A total of 174 patients with cirrhosis of the liver, 28 with EHPVO and 51 healthy controls were studied for SIBO using glucose hydrogen breath test (GHBT). Persistent rise in breath hydrogen 12 ppm above basal (at least two readings) was considered diagnostic of SIBO. Of 174 patients (age 47.2 ± 11.9 years, 80.5% male) with cirrhosis due to various causes, 67 (38.5%) were in Child’s class A, 70 (40.2%) class B and 37 (21.7%) class C. Of the 174 patients with cirrhosis, 42 (24.14%) had SIBO as compared to 1 of 51 (1.9%) healthy controls (P < 0.0001). Patients with EHPVO had similar frequency of SIBO compared to healthy controls [2/28 (7.14%) vs 1/51 (1.97%), P = ns]. Frequency of SIBO in Child’s A, B and C was comparable [13 (18.6%) vs 16 (23.9%) and 13 (35.1%), respectively; P = ns]. Presence of SIBO were not related to ascites, etiology of cirrhosis, and degree of liver dysfunction. SIBO is common in patients with cirrhosis of the liver. Patients with EHPVO do not have higher frequency of SIBO than healthy subjects. SIBO in cirrhosis is not related to the degree of derangement in liver function or of portal hypertension.
Similar content being viewed by others
References
Nobre SR, Cabral JE, Gomes JJ, Leitão MC. In-hospital mortality in spontaneous bacterial peritonitis: a new predictive model. Eur J Gastroenterol Hepatol. 2008;20(12):1176–1181. doi:10.1097/MEG.0b013e32830607a2.
Angeloni S, Leboffe C, Parente A, et al. Effcacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice. World J Gastroenterol. 2008;14(17):2757–2762. doi:10.3748/wjg.14.2757.
Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol. 1993;18(3):353–358. doi:10.1016/S0168-8278(05)80280-6.
Sheer TA, Runyon BA. Spontaneous bacterial Peritonitis. Dig Dis. 2005;23:39–46. doi:10.1159/000084724.
Puri AS, Puri J, Ghoshal UC, et al. Frequency, microbial spectrum and outcome of spontaneous bacterial peritonitis in north India. Indian J Gastroenterol. 1996;15(3):86–89.
Sánchez E, Casafont F, Guerra A, de Benito I, Pons-Romero F. Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis. Rev Esp Enferm Dig. 2005;97(11):805–814.
Bauer TM, Steinbrückner B, Brinkmann FE, et al. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol. 2001;96(10):2962–2967. doi:10.1111/j.1572-0241.2001.04668.x.
Chesta J, Silva M, Thompson L, del Canto E, Defilippi C. Bacterial overgrowth in small intestine in patients with liver cirrhosis. Rev Med Chil. 1991;119(6):626–632.
Casafont Morencos F, de las Heras Castaño G, Martín Ramos L, López Arias MJ, Ledesma F, Pons Romero F. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci. 1995;40(6):1252–1256. doi:10.1007/BF02065533.
Chen M, Sun G, et al. Small bowel bacterial overgrowth and endotoxemia in cirrhosis. Zhonghua Nei Ke Za Zhi. 2002;41(7):459–461.
Chang CS, Chen GH, Lien HC, Yeh HZ. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 1998;28(5):1187–1189. doi:10.1002/hep.510280504.
Chang CS, Yang SS, Kao CH, Yeh HZ. Chen GHSmall intestinal bacterial overgrowth versus antimicrobial capacity in patients with spontaneous bacterial peritonitis. Scand J Gastroenterol. 2001;36(1):92–96. doi:10.1080/00365520150218110.
Gunnarsdottir SA, Sadik R, Shev S, et al. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol. 2003;98(6):1362–1370. doi:10.1111/j.1572-0241.2003.07475.x.
Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–649. doi:10.1002/bjs.1800600817.
Runyon BA, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol. 1994;21(5):792–796. doi:10.1016/S0168-8278(94)80241-6.
Yang CY, Chang CS, Chen GH. Small-intestinal bacterial overgrowth in patients with liver cirrhosis, diagnosed with glucose H2 or CH4 breath tests. Scand J Gastroenterol. 1998;33(8):867–871. doi:10.1080/00365529850171549.
Bode C, Kolepke R, Schäfer K, Bode JC. Breath hydrogen excretion in patients with alcoholic liver disease–evidence of small intestinal bacterial overgrowth. Z Gastroenterol. 1993;31(1):3–7.
Gupta N, Sahni V, Singh P, Das A, Kar P. Spontaneous bacterial peritonitis in isolated splenic vein thrombosis with portal hypertension. Indian J Gastroenterol. 2006;25:263–264.
Quera PR, Quigley EM, Madrid SAM. Small intestinal bacterial overgrowth. An update. Rev Med Chil. 2005;133(11):1361–1370.
Ghoshal UC, Dhar K, Chaudhuri S, Pal BB, Pal AK, Banerjee PK. Esophageal motility changes after endoscopic intravariceal sclerotherapy with absolute alcohol. Dis Esophagus. 2000;13(2):148–151. doi:10.1046/j.1442-2050.2000.00104.x.
Sadik R, Abrahamsson H, Björnsson E, Gunnarsdottir A, Stotzer PO. Etiology of portal hypertension may influence gastrointestinal transit. Scand J Gastroenterol. 2003;38(10):1039–1044. doi:10.1080/00365520310004939.
Reilly JA Jr, Quigley EM, Forst CF, Rikkers LF. Small intestinal transit in the portal hypertensive rat. Gastroenterology. 1991;100(3):670–674.
Madrid AM, Cumsille F, Defilippi C. Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease. Dig Dis Sci. 1997;42(4):738–742. doi:10.1023/A:1018899611006.
Savarino V, Mela GS, Zentilin P, et al. Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis. Hepatology. 1996;25(2):152–157. doi:10.1016/S0168-8278(96)80067-5.
Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology. 1984;4(1):53–58. doi:10.1002/hep.1840040109.
Lewis SJ, Franco S, Young G, O’Keefe SJ. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther. 1996;10(4):557–561. doi:10.1046/j.1365-2036.1996.d01-506.x.
Pereira SP, Gainsborough N, Dowling RH. Drug-induced hypochlorhydria causes high duodenal bacterial counts in the elderly. Aliment Pharmacol Ther. 1998;12(1):99–104. doi:10.1046/j.1365-2036.1998.00275.x.
Nelis GF, Engelage AH, Samson G. Does long-term inhibition of gastric acid secretion with omeprazole lead to small intestinal bacterial overgrowth? Neth J Med. 1994;45(3):93–100.
Bauer TM, Schwacha H, Steinbrückner B, et al. Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: poor performance of the glucose breath hydrogen test. J Hepatol. 2000;33(3):382–386. doi:10.1016/S0168-8278(00)80273-1.
Ghoshal UC, Ghoshal U, Das K, Misra A. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome, and its relationship with oro-cecal transit time. Indian J Gastroenterol. 2006;25(1):6–10.
Rana SV, Sinha SK, Sharma S, Kaur H, Bhasin DK, Singh K. Effect of predominant Methanogenic Flora on outcome of lactose hydrogen breath test in controls and irritable bowel syndrome patients of North India. Dig Dis Sci. 2009;54(1):132–135. doi:10.1007/s10620-008-0315-x.
Llovet JM, Rodriguez-Iglesias P, Moitinho E, et al. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. J Hepatol. 1997;26:88–95. doi:10.1016/S0168-8278(97)80014-1.
Umgelter A, Reindl W, Miedaner M, Schmid RM, Huber W. Failure of current antibiotic first-line regimens and mortality in hospitalized patients with spontaneous bacterial peritonitis. Infection. 2009;37(1):2–8. doi:10.1007/s15010-008-8060-9.
Madrid AM, Hurtado C, Venegas M, Cumsille F, Defilippi C. Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function. Am J Gastroenterol. 2001;96(4):1251–1255. doi:10.1111/j.1572-0241.2001.03636.x.
Sandhu BS, Gupta R, Sharma J, Singh J, Murthy NS, Sarin SK. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites. J Gastroenterol Hepatol. 2005;20(4):599–605. doi:10.1111/j.1440-1746.2005.03796.x.
Pardo A, Bartolí R, Lorenzo-Zúñiga V, et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology. 2000;31(4):858–863. doi:10.1053/he.2000.5746.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lakshmi, C.P., Ghoshal, U.C., Kumar, S. et al. Frequency and Factors Associated with Small Intestinal Bacterial Overgrowth in Patients with Cirrhosis of the Liver and Extra Hepatic Portal Venous Obstruction. Dig Dis Sci 55, 1142–1148 (2010). https://doi.org/10.1007/s10620-009-0826-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-009-0826-0